Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott E Walker

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 8, 2019
Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adultsPriya Patel, Paul C Nathan, Scott E Walker, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 10, 2018
Steady-State Pharmacokinetics of Oral Ciprofloxacin in Continuous Cycling Peritoneal Dialysis Patients: Brief ReportColin Lee, Sandra A N Walker, Lesley Palmay, et al.
Burns : Journal of the International Society for Burn Injuries|June 26, 2017
A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patientsColin Lee, Sandra A N Walker, Scott E Walker, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 20, 2004
Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysisSharon M Yeung, Scott E Walker, Sandra A N Tailor, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2010
Mortality in a heterogeneous population of low-risk febrile neutropenic patients treated initially with cefazolin and tobramycinFrancesca Le Piane, Sandra An Walker, Scott E Walker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Impact of a Comprehensive Antimicrobial Stewardship Program on Institutional Burden of Antimicrobial Resistance: A 14-Year Controlled Interrupted Time-series StudyChristine Peragine, Sandra A N Walker, Andrew Simor, et al.
International Journal of Pharmaceutical Compounding|August 18, 2023
Chemical Stability of Epinephrine 10 mcg/mL Diluted in 0.9% Sodium Chloride and Stored in Polypropylene Syringes at 4 degrees C and 25 degrees CRoxanne Hook, Ashleigh Neault, Devan Scharrer, et al.
Pharmacoeconomics|April 9, 2011
The direct medical costs associated with suspected heparin-induced thrombocytopeniaNatasha Nanwa, Nicole Mittmann, Sandra Knowles, et al.
Psychoneuroendocrinology|June 23, 2009
Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery diseaseWalter Swardfager, Nathan Herrmann, Yekta Dowlati, et al.
Burns : Journal of the International Society for Burn Injuries|May 14, 2013
Identification of predictors of early infection in acute burn patientsLaura Schultz, Sandra A N Walker, Marion Elligsen, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 8, 2019
Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adultsPriya Patel, Paul C Nathan, Scott E Walker, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 10, 2018
Steady-State Pharmacokinetics of Oral Ciprofloxacin in Continuous Cycling Peritoneal Dialysis Patients: Brief ReportColin Lee, Sandra A N Walker, Lesley Palmay, et al.
Burns : Journal of the International Society for Burn Injuries|June 26, 2017
A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patientsColin Lee, Sandra A N Walker, Scott E Walker, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 20, 2004
Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysisSharon M Yeung, Scott E Walker, Sandra A N Tailor, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2010
Mortality in a heterogeneous population of low-risk febrile neutropenic patients treated initially with cefazolin and tobramycinFrancesca Le Piane, Sandra An Walker, Scott E Walker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Impact of a Comprehensive Antimicrobial Stewardship Program on Institutional Burden of Antimicrobial Resistance: A 14-Year Controlled Interrupted Time-series StudyChristine Peragine, Sandra A N Walker, Andrew Simor, et al.
International Journal of Pharmaceutical Compounding|August 18, 2023
Chemical Stability of Epinephrine 10 mcg/mL Diluted in 0.9% Sodium Chloride and Stored in Polypropylene Syringes at 4 degrees C and 25 degrees CRoxanne Hook, Ashleigh Neault, Devan Scharrer, et al.
Pharmacoeconomics|April 9, 2011
The direct medical costs associated with suspected heparin-induced thrombocytopeniaNatasha Nanwa, Nicole Mittmann, Sandra Knowles, et al.
Psychoneuroendocrinology|June 23, 2009
Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery diseaseWalter Swardfager, Nathan Herrmann, Yekta Dowlati, et al.
Burns : Journal of the International Society for Burn Injuries|May 14, 2013
Identification of predictors of early infection in acute burn patientsLaura Schultz, Sandra A N Walker, Marion Elligsen, et al.
Pageof 4